Results 101 to 110 of about 20,537 (194)

Phase II trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors SWOG/NCI experience: invasive mucinous or non-mucinous lepidic adenocarcinoma of the lung (formerly bronchioloalveolar carcinoma)

open access: yesTherapeutic Advances in Medical Oncology
Background: Anti-programmed death-1 (PD-1)/cytotoxic T lymphocyte antigen-4 antibodies are efficacious in various malignancies. Objectives: This study presents the first results of ipilimumab–nivolumab in invasive mucinous or non-mucinous lepidic ...
Young Kwang Chae   +14 more
doaj   +1 more source

Large-scale phenotyping and comparative genomics reveal genetic features of Listeria persistence in epithelial cells. [PDF]

open access: yesPLoS Pathog
Lotoux A   +13 more
europepmc   +1 more source

Parametric Bayesian modelling of tuberculosis mortality determinants and facility level heterogeneity effect using Gamma and Gaussian shared frailty techniques. [PDF]

open access: yesBMC Infect Dis
Tamuzi JL   +12 more
europepmc   +1 more source

Bayesian Regression Modeling with INLA

open access: yesJournal of the Royal Statistical Society Series A: Statistics in Society, 2019
openaire   +1 more source

Spatial and spatio-temporal county-level trends in COVID-19 mortality and emergency department visits in U.S. with R-INLA. [PDF]

open access: yesSpat Spatiotemporal Epidemiol
Khan D   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy